
    
      This study will be controlled, double-blind clinical trial versus placebo, with random
      assignment to evaluate the effect of pentoxifylline on apoptosis and senescence of leukemic
      blasts from remission induction in pediatric patients with newly diagnosed acute
      lymphoblastic leukemia, as well as to address pentoxifylline efficacy and safety in this
      group of patients.
    
  